| 摘要 |
<p>The invention relates to a method and composition for a selective apoptosis factor that will specifically kill cancer and other target cells but not normal cells. The method is for use in the cancer therapy, for anti-aging, bone disease as well as other applications in human or animals. This invention is focused on the alpha 2-HS glycoproteins (AHSG) and their related clones.</p> |
